🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this randomized clinical trial is to learn if topical treatment...
Status
Recruiting
Location
Genesis Cancer and Blood Institute
Start Date
2025-08-25
Trial ID
NCT06830863
This study aims to evaluate the efficacy and safety of probiotics for the p...
Status
Recruiting
Location
Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Start Date
2025-08-07
Trial ID
NCT06892093
Treatments Being Tested
PreTerm Labor (prior to 37 weeks gestation) is the largest single cause of ...
Status
Terminated
Location
GSK Investigational Site
Start Date
2007-03
Trial ID
NCT00449709
Treatments Being Tested
MKC-NI-002 is a Phase 1b, randomized, double-blind, placebo-controlled stud...
Status
Completed
Location
VALDI
Start Date
2025-12-22
Trial ID
NCT07344558
Treatments Being Tested
This is a Phase 1, randomized, double-blinded, placebo-controlled, single a...
Status
Completed
Location
CMAX Clinical Research Pty Ltd
Start Date
2025-03-12
Trial ID
NCT06870058
Treatments Being Tested
The Zambia PCPI study will measure the effect of the parasite genotypes ass...
Status
Completed
Location
Nchelenge District
Start Date
2024-07-24
Trial ID
NCT06166498
Treatments Being Tested
This Pilot study will investigate the bioavailability in fasting women of 2...
Status
Completed
Location
Innolab
Start Date
2019-11-09
Trial ID
NCT04193852
The purpose of this study is to complete the total safety database size for...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-07-19
Trial ID
NCT03954743
This phase I/II trial studies the side effects of panobinostat nanoparticle...
Status
Completed
Location
University of California, San Francisco
Start Date
2018-05-22
Trial ID
NCT03566199
Treatments Being Tested
This open-label Phase I study is designed to determine the maximum tolerate...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2009-06-02
Trial ID
NCT00875693
Treatments Being Tested